Deciphering the state of immune silence in fatal COVID-19 patients P Bost, F De Sanctis, S Canè, S Ugel, K Donadello, M Castellucci, D Eyal, ... Nature communications 12 (1), 1428, 2021 | 112 | 2021 |
The risk of dengue virus transmission in Dar es Salaam, Tanzania during an epidemic period of 2014 LEG Mboera, CN Mweya, SF Rumisha, PK Tungu, G Stanley, ... PLoS neglected tropical diseases 10 (1), e0004313, 2016 | 106 | 2016 |
Nucleic acid amplification tests on respiratory samples for the diagnosis of coronavirus infections: a systematic review and meta-analysis MM Hellou, A Górska, F Mazzaferri, E Cremonini, E Gentilotti, P De Nardo, ... Clinical Microbiology and Infection 27 (3), 341-351, 2021 | 91 | 2021 |
Multi-Criteria Decision Analysis to prioritize hospital admission of patients affected by COVID-19 in low-resource settings with hospital-bed shortage P De Nardo, E Gentilotti, F Mazzaferri, E Cremonini, P Hansen, ... International Journal of Infectious Diseases 98, 494-500, 2020 | 76 | 2020 |
Reliability and validity of using telephone calls for post-discharge surveillance of surgical site infection following caesarean section at a tertiary hospital in Tanzania B Nguhuni, P De Nardo, E Gentilotti, Z Chaula, C Damian, P Mencarini, ... Antimicrobial Resistance & Infection Control 6, 1-6, 2017 | 72 | 2017 |
Post-caesarean section surgical site infections at a Tanzanian tertiary hospital: a prospective observational study P De Nardo, E Gentilotti, B Nguhuni, F Vairo, Z Chaula, E Nicastri, ... Journal of Hospital Infection 93 (4), 355-359, 2016 | 69 | 2016 |
Clinical, virologic, and epidemiologic characteristics of dengue outbreak, Dar es Salaam, Tanzania, 2014 F Vairo, LEG Mboera, P De Nardo, NM Oriyo, S Meschi, SF Rumisha, ... Emerging infectious diseases 22 (5), 895, 2016 | 62 | 2016 |
IgG against dengue virus in healthy blood donors, Zanzibar, Tanzania F Vairo, E Nicastri, SM Yussuf, A Cannas, S Meschi, MAA Mahmoud, ... Emerging infectious diseases 20 (3), 465, 2014 | 47 | 2014 |
Haemolytic anaemia in an HIV-infected patient with severe falciparum malaria after treatment with oral artemether-lumefantrine A Corpolongo, P De Nardo, P Ghirga, E Gentilotti, R Bellagamba, ... Malaria Journal 11, 1-4, 2012 | 40 | 2012 |
Diagnostic accuracy of point-of-care tests in acute community-acquired lower respiratory tract infections. A systematic review and meta-analysis E Gentilotti, P De Nardo, E Cremonini, A Górska, F Mazzaferri, ... Clinical Microbiology and Infection 28 (1), 13-22, 2022 | 37 | 2022 |
Haemolytic anaemia after oral artemether–lumefantrine treatment in a patient affected by severe imported falciparum malaria P De Nardo, A Oliva, ML Giancola, P Ghirga, P Mencarini, M Bibas, ... Infection 41, 863-865, 2013 | 34 | 2013 |
HIV-1 drug resistance in recently HIV-infected pregnant mother’s naïve to antiretroviral therapy in Dodoma urban, Tanzania F Vairo, E Nicastri, G Liuzzi, Z Chaula, B Nguhuni, N Bevilacqua, F Forbici, ... BMC infectious diseases 13, 1-8, 2013 | 25 | 2013 |
Implementing a combined infection prevention and control with antimicrobial stewardship joint program to prevent caesarean section surgical site infections and antimicrobial … E Gentilotti, P De Nardo, B Nguhuni, A Piscini, C Damian, F Vairo, ... Antimicrobial Resistance & Infection Control 9, 1-11, 2020 | 22 | 2020 |
Host immunological responses facilitate development of SARS-CoV-2 mutations in patients receiving monoclonal antibody treatments A Gupta, A Konnova, M Smet, M Berkell, A Savoldi, M Morra, ... The Journal of clinical investigation 133 (6), 2023 | 20 | 2023 |
Exploratory data on the clinical efficacy of monoclonal antibodies against SARS-CoV-2 Omicron Variant of Concern F Mazzaferri, M Mirandola, A Savoldi, P De Nardo, M Morra, M Tebon, ... Elife 11, e79639, 2022 | 17 | 2022 |
A retrospective evaluation of bites at risk of rabies transmission across 7 years: The need to improve surveillance and reporting systems for rabies elimination P De Nardo, E Gentilotti, F Vairo, B Nguhuni, Z Chaula, E Nicastri, ... PloS one 13 (7), e0197996, 2018 | 17 | 2018 |
Determination of P-glycoprotein surface expression and functional ability after in vitro treatment with darunavir or raltegravir in lymphocytes of healthy donors M Tempestilli, E Gentilotti, C Tommasi, E Nicastri, F Martini, P De Nardo, ... International Immunopharmacology 16 (4), 492-497, 2013 | 17 | 2013 |
Total hip replacement infected with Mycobacterium tuberculosis complicated by Addison disease and psoas muscle abscess: a case report P De Nardo, A Corpolongo, A Conte, E Gentilotti, P Narciso Journal of Medical Case Reports 6, 1-5, 2012 | 17 | 2012 |
Treatment of recurrent hepatocellular carcinoma with sorafenib in a HIV/HCV co-infected patient in HAART: a case report P De Nardo, M Viscione, A Corpolongo, R Bellagamba, G Vennarecci, ... Infectious Agents and Cancer 7, 1-4, 2012 | 17 | 2012 |
Septic shock after seasonal influenza vaccination in an HIV-infected patient during treatment with etanercept for rheumatoid arthritis: a case report P De Nardo, R Bellagamba, A Corpolongo, E Gentilotti, F Taglietti, ... Clinical and Vaccine Immunology 20 (5), 761-764, 2013 | 15 | 2013 |